Xiaodong Su

2.0k total citations
38 papers, 752 citations indexed

About

Xiaodong Su is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Xiaodong Su has authored 38 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 14 papers in Oncology. Recurrent topics in Xiaodong Su's work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaodong Su is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaodong Su collaborates with scholars based in China, United States and Hong Kong. Xiaodong Su's co-authors include Xiaoxia Li, Robert Chunhua Zhao, Xian Xiao, Armand Keating, Meiqian Xu, Yongbin Lin, Tiehua Rong, Dongrong Situ, Kai Yu and Zheng Wang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Physical Chemistry B and Oncogene.

In The Last Decade

Xiaodong Su

34 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Su China 16 311 288 212 207 105 38 752
Jennifer Doss United States 10 269 0.9× 260 0.9× 173 0.8× 205 1.0× 49 0.5× 10 624
Natasha Musrap Canada 12 295 0.9× 155 0.5× 149 0.7× 164 0.8× 53 0.5× 15 628
Ye Tian China 18 382 1.2× 229 0.8× 246 1.2× 191 0.9× 180 1.7× 79 867
Gaëlle Tachon France 15 210 0.7× 137 0.5× 214 1.0× 335 1.6× 53 0.5× 29 656
Masaaki Ichinoe Japan 18 469 1.5× 171 0.6× 136 0.6× 245 1.2× 126 1.2× 58 816
Arif Y. Shaikh United States 9 272 0.9× 115 0.4× 145 0.7× 291 1.4× 86 0.8× 15 688
Ching Ouyang United States 15 385 1.2× 195 0.7× 355 1.7× 578 2.8× 118 1.1× 31 1.1k
Wataru Sakamoto Japan 19 393 1.3× 131 0.5× 152 0.7× 396 1.9× 95 0.9× 65 837
Frédéric Commo France 13 247 0.8× 226 0.8× 171 0.8× 273 1.3× 104 1.0× 16 774
Oliver J. Stoetzer Germany 14 256 0.8× 97 0.3× 113 0.5× 206 1.0× 55 0.5× 29 625

Countries citing papers authored by Xiaodong Su

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Su more than expected).

Fields of papers citing papers by Xiaodong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Su. The network helps show where Xiaodong Su may publish in the future.

Co-authorship network of co-authors of Xiaodong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Su. A scholar is included among the top collaborators of Xiaodong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Su. Xiaodong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Su, Xiaodong, et al.. (2024). Advances in the use of dexmedetomidine during the perioperative period to improve postoperative sleep quality in patients undergoing surgery. Journal of International Medical Research. 52(11). 3649351643–3649351643.
4.
Li, Guanzhang, Jing Feng, Fan Wu, et al.. (2023). Stalled oligodendrocyte differentiation in IDH-mutant gliomas. Genome Medicine. 15(1). 24–24. 18 indexed citations
5.
Su, Xiaodong, Guangyu Luo, Zhiqiang Wang, et al.. (2023). Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial. Journal of Translational Medicine. 21(1). 411–411. 17 indexed citations
6.
Su, Xiaodong, Guangyu Luo, Haoqiang He, et al.. (2023). Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?. Thoracic Cancer. 14(13). 1153–1161. 5 indexed citations
7.
Zheng, Xiaobo, Jinen Song, Chune Yu, et al.. (2022). Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis. Signal Transduction and Targeted Therapy. 7(1). 60–60. 47 indexed citations
8.
Zheng, Yinli, Jinjun Wu, Ru Deng, et al.. (2021). G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript. Oncogene. 41(4). 515–526. 19 indexed citations
9.
Yu, Kai, Yuqiong Hu, Fan Wu, et al.. (2020). Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies. National Science Review. 7(8). 1306–1318. 98 indexed citations
10.
Caruso, Francesca Pia, Luciano Garofano, Fulvio D’Angelo, et al.. (2020). A map of tumor–host interactions in glioma at single-cell resolution. GigaScience. 9(10). 31 indexed citations
11.
Su, Xiaodong & Shuai Yao. (2020). Macromolecules and Antibody-Based Drugs. Advances in experimental medicine and biology. 1248. 485–530. 5 indexed citations
12.
Xu, Meiqian, Xiaoxia Li, Xiaodong Su, et al.. (2018). Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. Journal of Hematology & Oncology. 11(1). 82–82. 126 indexed citations
13.
Yu, Kai, Yang Yu, Xiaoyan Tang, et al.. (2016). Transcriptome analyses of insect cells to facilitate baculovirus-insect expression. Protein & Cell. 7(5). 373–382. 10 indexed citations
14.
Zhao, Ze-Rui, Shaoyan Xi, Wěi Li, et al.. (2015). Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma. Lung Cancer. 90(3). 604–609. 28 indexed citations
15.
Chen, Huimin, Kai Yu, Xiaoyan Tang, et al.. (2015). Enhanced expression and phosphorylation of the MET oncoprotein by glioma‐specific PTPRZ1–MET fusions. FEBS Letters. 589(13). 1437–1443. 17 indexed citations
16.
Li, Xiangyang, et al.. (2014). The Activity, Protein, and mRNA Expression of CYP2E1 and CYP3A1 in Rats after Exposure to Acute and Chronic High Altitude Hypoxia. High Altitude Medicine & Biology. 15(4). 491–496. 15 indexed citations
17.
Huang, Qingyuan, Xiaodong Su, Amos Éla Bella, et al.. (2014). Clinicopathological features and outcome of gastric metastases from primary lung cancer: A case report and systematic review. Oncology Letters. 9(3). 1373–1379. 15 indexed citations
19.
Li, Xiangyang, Xuejun Wang, Yongping Li, et al.. (2014). Effect of Exposure to Acute and Chronic High-Altitude Hypoxia on the Activity and Expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in Rats. Pharmacology. 93(1-2). 76–83. 33 indexed citations
20.
Zhao, Ze-Rui, Jinfeng Wang, Yongbin Lin, et al.. (2013). Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance. Medical Oncology. 31(1). 810–810. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026